Skip to content

144Accepted Nov 4, 4:48 PM ET

Werewolf Therapeutics, Inc. 144

UBS Oncology Impact Fund L.P.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

4:48 PM

Nov 4, 2025

Filed

Nov 4, 2025

Documents

2

Size

44.9 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.